McKesson has agreed to pay a record civil penalty of $150 million to settle DEA and Justice Department allegations that the drug distributor failed to report suspicious orders of opioids.

The deal stipulates that McKesson must suspend the sales of controlled substances from distribution centers in Colorado, Ohio, Michigan and Florida for several years to settle claims that it violated the Controlled Substance Act. DoJ did not specify the duration of the suspension.

Under the deal, McKesson will also have to follow enhanced compliance terms — which include improving staffing and periodic audits. Additionally, it will have to maintain an independent monitor to assess its compliance. This is the first time a CSA settlement has required an independent monitor, the DoJ said.